Monday, 1 June 2015

New Drug Keeps Common Breast Cancer Under Control Longer

Adding Ibrance to standard hormone therapy kept disease from progressing for nine months

HealthDay news image

Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Medicines via MedlinePlus Health News Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)